Home LiteratureArticle Details
PMID: 23397052 Published · ppublish English Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Impaired cliff avoidance reaction in dopamine transporter knockout mice.

Psychopharmacology ·Vol. 227 ·No. 4 ·2013-06-00 ·Pages 741-9

Yamashita M, Sakakibara Y, Hall FS, Numachi Y, Yoshida S, Kobayashi H, Uchiumi O, Uhl GR, Kasahara Y, Sora I

Abstract

Impulsivity is a key feature of disorders that include attention-deficit/hyperactivity disorder (ADHD). The cliff avoidance reaction (CAR) assesses maladaptive impulsive rodent behavior. Dopamine transporter knockout (DAT-KO) mice display features of ADHD and are candidates in which to test other impulsive phenotypes. Impulsivity of DAT-KO mice was assessed in the CAR paradigm. For comparison, attentional deficits were also assessed in prepulse inhibition (PPI) in which DAT-KO mice have been shown to exhibit impaired sensorimotor gating. DAT-KO mice exhibited a profound CAR impairment compared to wild-type (WT) mice. As expected, DAT-KO mice showed PPI deficits compared to WT mice. Furthermore, the DAT-KO mice with the most impaired CAR exhibited the most severe PPI deficits. Treatment with methylphenidate or nisoxetine ameliorated CAR impairments in DAT-KO mice. These results suggest that DAT-KO mice exhibit impulsive CAR behavior that correlates with their PPI deficits. Blockade of monoamine transporters, especially the norepinephrine transporter (NET) in the prefrontal cortex (PFC), may contribute to pharmacological improvement of impulsivity in these mice.

MeSH Terms
Animals Attention Deficit Disorder with Hyperactivity/physiopathology Avoidance Learning/drug effects,physiology Behavior, Animal/drug effects Disease Models, Animal Dopamine Plasma Membrane Transport Proteins/genetics Fluoxetine/analogs & derivatives,pharmacology Impulsive Behavior/physiopathology Male Methylphenidate/pharmacology Mice Mice, Inbred C57BL Mice, Knockout Norepinephrine Plasma Membrane Transport Proteins/metabolism Reflex, Startle/drug effects Sensory Gating/drug effects,physiology
Chemicals
Dopamine Plasma Membrane Transport Proteins Norepinephrine Plasma Membrane Transport Proteins Fluoxetine nisoxetine Methylphenidate
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Yamashita Motoyasu
Department of Biological Psychiatry, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.
Sakakibara Yasufumi
Hall F Scott
Numachi Yohtaro
Yoshida Sumiko
Kobayashi Hideaki
Uchiumi Osamu
Uhl George R
Kasahara Yoshiyuki
Sora Ichiro
References (44)
44 references, click to expand
  1. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.
    Brain Res. 1973 Jun 15;55(2):369-82 PMID: 4145950
  2. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.
    Biol Psychiatry. 2006 Nov 15;60(10):1111-20 PMID: 16806100
  3. Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate.
    J Neurosci. 2009 Nov 11;29(45):14086-99 PMID: 19906957
  4. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
    Neurochem Int. 2008 Feb;52(3):457-69 PMID: 17881090
  5. Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice.
    Neuropsychopharmacology. 2012 Oct;37(11):2522-30 PMID: 22781838
  6. Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device.
    J Child Adolesc Psychopharmacol. 2011 Oct;21(5):433-44 PMID: 22040189
  7. Hyperactivity in novel environment with increased dopamine and impaired novelty preference in apoptosis signal-regulating kinase 1 (ASK1)-deficient mice.
    Neurosci Res. 2010 Mar;66(3):313-20 PMID: 20006657
  8. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters.
    Pharmacol Ther. 2011 Mar;129(3):352-68 PMID: 21147164
  9. Neurobiology of ADHD.
    Neuropharmacology. 2009 Dec;57(7-8):579-89 PMID: 19627998
  10. Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry.
    Pharmacol Biochem Behav. 2008 Aug;90(2):250-60 PMID: 18272211
  11. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD.
    Psychol Bull. 1997 Jan;121(1):65-94 PMID: 9000892
  12. Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate.
    Curr Neuropharmacol. 2008 Dec;6(4):322-8 PMID: 19587853
  13. Current perspectives of the roles of the central norepinephrine system in anxiety and depression.
    Depress Anxiety. 2010 Apr;27(4):339-50 PMID: 19960531
  14. Assaying dissociable elements of behavioural inhibition and impulsivity: translational utility of animal models.
    Curr Opin Pharmacol. 2011 Oct;11(5):534-9 PMID: 21763200
  15. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.
    Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7699-704 PMID: 9636213
  16. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
    Neuropsychopharmacology. 2004 Oct;29(10):1790-9 PMID: 15226739
  17. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons.
    Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):11035-40 PMID: 12958210
  18. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.
    Pharmacol Biochem Behav. 2011 Aug;99(2):211-6 PMID: 21295057
  19. Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse.
    Hum Mol Genet. 2011 Dec 1;20(23):4666-83 PMID: 21903668
  20. Animal models of attention-deficit/hyperactivity disorder.
    Biol Pharm Bull. 2011;34(9):1373-6 PMID: 21881220
  21. On inhibition/disinhibition in developmental psychopathology: views from cognitive and personality psychology and a working inhibition taxonomy.
    Psychol Bull. 2000 Mar;126(2):220-46 PMID: 10748641
  22. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.
    Science. 1999 Jan 15;283(5400):397-401 PMID: 9888856
  23. Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD).
    Psychopharmacology (Berl). 2009 Jan;202(1-3):531-9 PMID: 18818905
  24. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Neuropsychopharmacology. 2002 Nov;27(5):699-711 PMID: 12431845
  25. Impairment of cliff avoidance reaction induced by subchronic methamphetamine administration and restraint stress: comparison between two inbred strains of rats.
    Prog Neuropsychopharmacol Biol Psychiatry. 1998 Aug;22(6):1023-32 PMID: 9789885
  26. Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene.
    Neuropsychopharmacology. 2005 Oct;30(10):1818-31 PMID: 15856082
  27. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    J Neurochem. 2010 Jul;114(1):259-70 PMID: 20403082
  28. Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder.
    Biol Psychiatry. 2003 Dec 15;54(12):1465-8 PMID: 14675812
  29. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
    Neuropsychopharmacology. 2006 Oct;31(10):2132-9 PMID: 16407898
  30. Profound neuronal plasticity in response to inactivation of the dopamine transporter.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):4029-34 PMID: 9520487
  31. Prepulse inhibition and genetic mouse models of schizophrenia.
    Behav Brain Res. 2009 Dec 7;204(2):282-94 PMID: 19397931
  32. Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition.
    Neurosci Biobehav Rev. 2010 Jan;34(1):50-72 PMID: 19615404
  33. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
    Neurosci Biobehav Rev. 2007;31(4):597-618 PMID: 17316796
  34. Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.
    Neuropharmacology. 2013 Jan;64:348-56 PMID: 22809709
  35. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.
    Br J Pharmacol. 2011 Oct;164(4):1301-21 PMID: 21410459
  36. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.
    Cell. 2000 Mar 31;101(1):57-66 PMID: 10778856
  37. Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.
    J Psychopharmacol. 2011 Jul;25(7):934-43 PMID: 21421642
  38. The neuropharmacology of impulsive behaviour.
    Trends Pharmacol Sci. 2008 Apr;29(4):192-9 PMID: 18304658
  39. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
    Eur J Pharmacol. 1989 Aug 3;166(3):359-66 PMID: 2553433
  40. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists.
    J Neurosci. 2001 Jan 1;21(1):305-13 PMID: 11150348
  41. Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice.
    Behav Pharmacol. 2000 Jun;11(3-4):279-90 PMID: 11103882
  42. Prostaglandin E receptor EP1 controls impulsive behavior under stress.
    Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16066-71 PMID: 16247016
  43. Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice.
    Neuroscience. 2003;116(4):1123-30 PMID: 12617953
  44. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter.
    J Neurosci. 1998 Apr 1;18(7):2697-708 PMID: 9502827
Article Info
Journal
Psychopharmacology
Abbr.
Psychopharmacology (Berl)
ISSN
1432-2072
Published
2013-06-00
Epub
2013-00-09
Pages
741-9
Language
English
Region
Germany
NLM ID
7608025
Subset
IM
Grants
Intramural NIH HHS · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com